Olga N Pozharitskaya1, Marina V Karlina1, Alexander N Shikov2, Vera M Kosman1, Valery G Makarov1, Eudald Casals3, Jessica M Rosenholm3. 1. Saint Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, 188663, Kuzmolovo P 245, Russia. 2. Saint Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, 188663, Kuzmolovo P 245, Russia. spb.pharmacy@gmail.com. 3. Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, BioCity (3rd Floor), Tykistökatu 6A, 20520, Turku, Finland.
Abstract
BACKGROUND AND OBJECTIVES: Betulin is a triterpene extracted from the cork layer of the outer bark of Betula spp. It has a wide spectrum of pharmacological activities, including being lung protective; however, its bioavailability is low. To increase its bioavailability, betulin was entrapped in a nanosystem (BN). In this study, we investigated the pharmacokinetics and tissue distribution of nanosystem-entrapped betulin after single dose endotracheal administration to rats. METHOD: Betulin was nanosystem-entrapped using a solvent exchange technique. The surface morphology and size of the nanosystem were characterized by transmission electron microscopy and dynamic light scattering. The plasma and tissue concentrations of betulin were determined using a validated high-performance liquid chromatography method. RESULTS: The highest concentration of betulin was found in lungs and liver, and the lowest in the heart. Betulin did not penetrate highly vascularized tissues or tissue with an average degree of vascularization, nor did it cross the blood-brain barrier. Tissue availability in the lungs was 1.3 times higher for BN than for free betulin. Betulin was detected in the bloodstream at 15 min after administration of BN compared with only at 1 h after administration of free betulin. Penetration of betulin in the liver tissue was characterized by a high degree of intensity both for BN and free betulin. Betulin in the heart tissue was detected in much smaller quantities than in the liver. CONCLUSION: Entrapment of betulin in nanosystem form shows promise as a novel strategy in the treatment of pulmonary diseases.
BACKGROUND AND OBJECTIVES:Betulin is a triterpene extracted from the cork layer of the outer bark of Betula spp. It has a wide spectrum of pharmacological activities, including being lung protective; however, its bioavailability is low. To increase its bioavailability, betulin was entrapped in a nanosystem (BN). In this study, we investigated the pharmacokinetics and tissue distribution of nanosystem-entrapped betulin after single dose endotracheal administration to rats. METHOD:Betulin was nanosystem-entrapped using a solvent exchange technique. The surface morphology and size of the nanosystem were characterized by transmission electron microscopy and dynamic light scattering. The plasma and tissue concentrations of betulin were determined using a validated high-performance liquid chromatography method. RESULTS: The highest concentration of betulin was found in lungs and liver, and the lowest in the heart. Betulin did not penetrate highly vascularized tissues or tissue with an average degree of vascularization, nor did it cross the blood-brain barrier. Tissue availability in the lungs was 1.3 times higher for BN than for free betulin. Betulin was detected in the bloodstream at 15 min after administration of BN compared with only at 1 h after administration of free betulin. Penetration of betulin in the liver tissue was characterized by a high degree of intensity both for BN and free betulin. Betulin in the heart tissue was detected in much smaller quantities than in the liver. CONCLUSION: Entrapment of betulin in nanosystem form shows promise as a novel strategy in the treatment of pulmonary diseases.
Authors: John S Patton; Joseph D Brain; Lee A Davies; Jennifer Fiegel; Mark Gumbleton; Kwang-Jin Kim; Masahiro Sakagami; Rita Vanbever; Carsten Ehrhardt Journal: J Aerosol Med Pulm Drug Deliv Date: 2010-12 Impact factor: 2.849
Authors: Olli Salin; Sami Alakurtti; Leena Pohjala; Antti Siiskonen; Viola Maass; Matthias Maass; Jari Yli-Kauhaluoma; Pia Vuorela Journal: Biochem Pharmacol Date: 2010-07-06 Impact factor: 5.858
Authors: Alexander N Shikov; Olga N Pozharitskaya; Inna Miroshnyk; Sabiruddin Mirza; Irina N Urakova; Samuli Hirsjärvi; Valery G Makarov; Jyrki Heinämäki; Jouko Yliruusi; Raimo Hiltunen Journal: Int J Pharm Date: 2009-05-06 Impact factor: 5.875
Authors: Olga N Pozharitskaya; Alexander N Shikov; Natalya M Faustova; Ekaterina D Obluchinskaya; Vera M Kosman; Heikki Vuorela; Valery G Makarov Journal: Mar Drugs Date: 2018-04-18 Impact factor: 5.118
Authors: Daria Niewolik; Barbara Bednarczyk-Cwynar; Piotr Ruszkowski; Tomasz R Sosnowski; Katarzyna Jaszcz Journal: Int J Mol Sci Date: 2021-01-22 Impact factor: 5.923
Authors: Igor V Krasilnikov; Aleksandr V Kudriavtsev; Anna V Vakhrusheva; Maria E Frolova; Aleksandr V Ivanov; Marina A Stukova; Ekaterina A Romanovskaya-Romanko; Kirill A Vasilyev; Nataliya V Mushenkova; Artur A Isaev Journal: Vaccines (Basel) Date: 2022-01-02
Authors: Daria Niewolik; Barbara Bednarczyk-Cwynar; Piotr Ruszkowski; Alicja Kazek-Kęsik; Grzegorz Dzido; Katarzyna Jaszcz Journal: Pharmaceutics Date: 2022-03-06 Impact factor: 6.321